• 1
    Iruela-Arispe ML, Liska DJ, Sage EH, Bornstein P 1993 Differential expression of thrombospondin 1, 2, and 3 during murine development. Dev Dyn 197:4056.
  • 2
    Tooney PA, Sakai T, Sakai K, Aeschlimann D, Mosher DF 1998 Restricted localization of thrombospondin-2 protein during mouse embryogenesis: a comparison to thrombospondin-1. Matrix Biol 17:131143.
  • 3
    Kyriakides TR, Zhu YH, Yang Z, Bornstein P 1998 The distribution of the matricellular protein, thrombospondin 2, in tissues of embryonic and adult mice. J Histochem Cytochem 46:10071015.
  • 4
    Kyriakides TR, Zhu YH, Smith LT, Bain SD, Yang Z, Lin MT, Danielson KG, Iozzo RV, LaMarca M, McKinney CE, Ginns EI, Bornstein P 1998 Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol 140:419430.
  • 5
    Yang Z, Kyriakides TR, Bornstein P 1998 Altered expression of integrins and matrix metalloproteinases in thrombospondin 2-null mouse fibroblasts. Mol Biol Cell 9:2488 (abstract).
  • 6
    Kyriakides TR, Leach KJ, Hoffman AS, Ratner BD, Bornstein, P, 1999 Mice that lack the angiogenesis inhibitor, thrombospondin-2, mount an altered foreign body reaction characterization by increased vascularity. Proc Natl Acad Sci U S A 96:44494454.
  • 7
    Kyriakides TR, Zhu YH, Tam JWY, Yang Z, Bornstein P 1999 Accelerated wound healing in mice with a disruption of the thrombospondin 2 gene. J Invest Dermatol 113:782787.
  • 8
    Lawler J, Sunday M, Thibert V, Duquette M, George EL, Rayburn H, Hynes RO 1998 Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest 101:982992.
  • 9
    Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N 1998 Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell 93:11591170.
  • 10
    Bornstein P 1995 Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin 1. J Cell Biol 130:503506.
  • 11
    Sherbina NV, Bornstein P 1992 Modulation of thrombospondin gene expression during osteoblast differentiation in MC3T3-E1 cells. Bone 13:197201.
  • 12
    Bornstein P, Devarayalu S, Li P, Disteche CM, Framson P 1991 A second thrombospondin gene in the mouse is similar in organization to thrombospondin 1 but does not respond to serum. Proc Natl Acad Sci U S A 88:86368640.
  • 13
    Grzesik WJ, Robey PG 1994 Bone matrix RGD glycoproteins: immunolocalization and interaction with human primary osteoblastic bone cells in vitro. J Bone Miner Res 9:487496.
  • 14
    Robey PG, Young MF, Fisher LW, McClain TD 1989 Thrombospondin is an osteoblast-derived component of mineralized extracellular matrix. J Cell Biol 108:719727.
  • 15
    Adams JC, Lawler J 1993 Diverse mechanisms for cell attachment to platelet thrombospondin. J Cell Sci 104:10611071.
  • 16
    Chen H, Sottile J, O'Rourke KM, Dixit VM, Mosher DF 1994 Properties of recombinant mouse thrombospondin 2 expressed in Spodoptera cells. J Biol Chem 269:3222632232.
  • 17
    Raugi GJ, Mumby SM, Ready CA, Bornstein P 1984 Location and partial characterization of the heparin-binding fragment of platelet thrombospondin. Thromb Res 36:165175.
  • 18
    Murphy-Ullrich JE, Gurusiddappa S, Frazier WA, Hook M 1993 Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity. J Biol Chem 268:2678426789.
  • 19
    Asch AS, Silbiger S, Heimer E, Nachman RL 1992 Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. Biochem Biophys Res Commun 182:12081217.
  • 20
    Gao AG, Frazier WA 1994 Identification of a receptor candidate for the carboxyl-terminal cell binding domain of thrombospondins. J Biol Chem 269:2965029657.
  • 21
    Schultz-Cherry S, Ribeiro S, Gentry L, Murphy-Ullrich JE 1994 Thrombospondin binds and activates the small and large forms of latent transforming growth factor-β in a chemically defined system. J Biol Chem 269:2677526782.
  • 22
    Schultz-Cherry S, Murphy-Ullrich JE 1993 Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism. J Cell Biol 122:923932.
  • 23
    Taraboletti G, Belotti D, Borsotti P, Vergani V, Rusnati M, Presta M, Giavazzi R 1997 The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor. Cell Growth Differ 8:471479.
  • 24
    Hogg PJ, Hotchkiss KA, Jimenez BM, Stathakis P, Chesterman CN 1997 Interaction of platelet-derived growth factor with thrombospondin 1. Biochem J 326:709716.
  • 25
    Armstrong LC, Kyriakides TR, Bornstein P 1999 The role of thrombospondin 12 in vascular development. In: WeirEK (ed.) The FetalNeonatal Pulmonary Circulation. Futura Publishing Co. Inc., Armonk, NY, pp. 87103.
  • 26
    Soriano P, Montgomery C, Geske R, Bradley A 1991 Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693702.
  • 27
    Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Boyle WJ 1997 Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309319.
  • 28
    Wiktor-Jedrzejczak W, Bartocci A, Ferrante AWJ, Ahmed-Ansari A, Sell KW, Pollard JW, Stanley ER 1990 Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci U S A 87:48284832.
  • 29
    Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, Moritz JD, Schu P, von Figura K 1998 Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci U S A 95:1345313458.
  • 30
    Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg A, Bradley A, Karsenty G 1996 Increased bone formation in osteocalcin-deficient mice. Nature 382:448452.
  • 31
    Erben RG, Scutt AM, Miao D, Kollenkirchen U, Haberey M 1997 Short-term treatment of rats with high dose 1,25-dihydroxyvitamin D3 stimulates bone formation and increases the number of osteoblast precursor cells in bone marrow. Endocrinology 138:46294635.
  • 32
    Jilka RL, Takahasi K, Munshi M, Williams DC, Roberson PK, Manolagas SC 1998 Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. J Clin Invest 101:19421950.
  • 33
    Dimai HP, Linkhart TA, Linkhart SG, Donahue LR, Beamer WG, Rosen CJ, Farley JR, Baylink DJ 1998 Alkaline phosphatase levels and osteoprogenitor cell numbers suggest bone formation may contribute to peak bone density differences between two inbred strains of mice. Bone 22:211216.
  • 34
    Kuhn JL, Goldstein SA, Feldkamp LA, Goulet RW, Jesion G 1990 Evaluation of a microcomputed tomography system to study trabecular bone structure. J Orthop Res 8:833842.
  • 35
    Bonadio J, Saunders TL, Tsai E, Goldstein SA, Morris-Wiman J, Brinkley L, Dolan DF, Altschuler RA, Hawkins JEJ, Bateman JF 1990 Transgenic mouse model of the mild dominant form of osteogenesis imperfecta. Proc Natl Acad Sci U S A 87:71457149.
  • 36
    Bain SD, Bailey MC, Celino DL, Lantry MM, Edwards MW 1993 High-dose estrogen inhibits bone resorption and stimulates bone formation in the ovariectomized mouse. J Bone Miner Res 8:435442.
  • 37
    Owen M, Friedenstein AJ 1988 Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp 136:4260.
  • 38
    Friedenstein AJ, Chailakhjan RK, Lalykina KS 1970 The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393403.
  • 39
    Jilka RL, Weinstein RS, Takahashi K, Parfitt AM, Manolagas SC 1996 Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J Clin Invest 97:17321740.
  • 40
    Muraglia A, Martin I, Cancedda R, Quarto R 1998 A nude mouse model for human bone formation in unloaded conditions. Bone 22:131S134S.
  • 41
    Stepan JJ, Presl J, Broulik P, Pacovsky V 1987 Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and in primary hyperparathyroidism. J Clin Endocrinol Metab 64:10791082.
  • 42
    Malaval L, Modrowski D, Gupta AK, Aubin JE 1994 Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures. J Cell Physiol 158:555572.
  • 43
    Canalis E, Pash J, Varghese S 1993 Skeletal growth factors. Crit Rev Eukaryot Gene Expr 3:155166.
  • 44
    Gronthos S, Simmons PJ 1995 The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood 85:929940.
  • 45
    Kuznetsov SA, Friedenstein AJ, Robey PG 1997 Factors required for bone marrow stromal fibroblast colony formation in vitro. Br J Haematol 97:561570.
  • 46
    Fried A, Shamay A, Wientroub S, Benayahu D 1996 Phenotypic expression of marrow cells when grown on various substrata. J Cell Biochem 61:246254.
  • 47
    Barou O, Laroche N, Palle S, Alexandrie C, Lafage-Proust M-H 1998 Pre-osteoblastic proliferation assessed with BrdU in undecalcified, epon-embedded adult rat trabecular bone. J Histochem Cytochem 45:11891195.
  • 48
    Fallon MD, Teitelbaum SL 1982 The interpretation of fluorescent tetracycline markers in the diagnosis of metabolic bone diseases. Hum Pathol 13:416417.
  • 49
    Friedenstein AJ, Latzinik NV, Gorskaya YF, Luria EA, Moskvina IL 1992 Bone marrow stromal colony formation requires stimulation by haemopoietic cells. Bone Miner 18:199213.
  • 50
    Thomson BM, Bennett J, Dean V, Triffitt J, Meikle MC, Loveridge N 1993 Preliminary characterization of porcine bone marrow stromal cells: skeletogenic potential, colony-forming activity, and response to dexamethasone, transforming growth factor beta, and basic fibroblast growth factor. J Bone Miner Res 8:11731183.
  • 51
    Locklin RM, Williamson MC, Beresford JN, Triffitt JT, Owen ME 1995 In vitro effects of growth factors and dexamethasone on rat marrow stromal cells. Clin Orthop 313:2735.
  • 52
    Martin I, Muraglia A, Campanile G, Cancedda R, Quarto R 1997 Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 138:44564462.
  • 53
    Nakamura T, Hanada K, Tamura M, Shibanushi T, Nigi H, Tagawa M, Fukumoto S, Matsumoto T 1995 Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology 136:12761284.
  • 54
    Nakamura K, Kawaguchi H, Aoyama I, Hanada K, Hiyama Y, Awa T, Tamura M, Kurokawa T 1997 Stimulation of bone formation by intraosseous application of recombinant basic fibroblast growth factor in normal and ovariectomized rabbits. J Orthop Res 15:307313.
  • 55
    Tanaka H, Liang CT 1995 Effect of platelet-derived growth factor on DNA synthesis and gene expression in bone marrow stromal cells derived from adult and old rats. J Cell Physiol 164:367375.
  • 56
    Mitlak BH, Finkelman RD, Hill EL, Li J, Martin B, Smith T, D'Andrea M, Antoniades HN, Lynch SE 1996 The effect of systemically administered PDGF-BB on the rodent skeleton. J Bone Miner Res 11:238247.
  • 57
    Cassiede P, Dennis JE, Ma F, Caplan AI 1996 Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF-β1 or PDGF-BB as assayed in vivo and in vitro. J Bone Miner Res 11:12641273.
  • 58
    Fromigue O, Marie PJ, Lomri A 1998 Bone morphogenetic protein-2 and transforming growth factor-β2 interact to modulate human bone marrow stromal cell proliferation and differentiation. J Cell Biochem 68:411426.
  • 59
    Rickard DJ, Kazhdan I, Leboy PS 1995 Importance of 1,25-dihydroxyvitamin D3 and the nonadherent cells of marrow for osteoblast differentiation from rat marrow stromal cells. Bone 16:671678.
  • 60
    Chen TL, Fry D 1999 Hormonal regulation of the osteoblastic phenotype expression in neonatal murine calvarial cells. Calcif Tissue Int 64:304309.
  • 61
    Ishida Y, Heersche JM 1999 Progesterone- and dexamethasone-dependent osteoprogenitors in bone cell populations derived from rat vertebrae are different and distinct. Endocrinology 140:32103218.
  • 62
    Klein G 1995 The extracellular matrix of the hematopoietic microenvironment. Experientia 51:914926.
  • 63
    Li J, Sensebe L, Herve P, Charbord P 1995 Nontransformed colony-derived stromal cell lines from normal human marrows. II. Phenotypic characterization and differentiation pathway. Exp Hematol 23:133141.
  • 64
    Mackie EJ, Ramsey S 1996 Modulation of osteoblast behaviour by tenascin. J Cell Sci 109:15971604.
  • 65
    Ohta M, Sakai T, Saga Y, Aizawa S, Saito M 1998 Suppression of hematopoietic activity in tenascin-C-deficient mice. Blood 91:40744083.
  • 66
    Bonadio J, Jepsen KJ, Mansoura MK, Jaenisch R, Kuhn JL, Goldstein SA 1993 A murine skeletal adaptation that significantly increases cortical bone mechanical properties. Implications for human skeletal fragility. J Clin Invest 92:16971705.
  • 67
    Frost HM 1987 Bone “mass” and the “mechanostat.” A proposal. Anat Rec 219:19.
  • 68
    Panetti TS, Chen H, Misenheimer TM, Getzler SB, Mosher DF 1997 Endothelial cell mitogenesis induced by LPA: Inhibition by thrombospondin-1 and thrombospondin-2. J Lab Clin Med 129:208216.
  • 69
    Volpert OV, Tolsma SS, Pellerin S, Feige JJ, Chen H, Mosher DF, Bouck N 1995 Inhibition of angiogenesis by thrombospondin-2. Biochem Biophys Res Commun 217:326332.
  • 70
    Rosen CJ, Dimai HP, Vereault D, Donahue LR, Beamer WG, Farley J, Linkhart S, Linkhart T, Mohan S, Baylink DJ 1997 Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities. Bone 21:217223.
  • 71
    Khosla S, Hassoun AA, Baker BK, Liu F, Zein NN, Whyte MP, Reasner CA, Nippoldt TB, Tiegs RD, Hintz RL, Conover CA 1998 Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults. J Clin Invest 101:21652173.
  • 72
    Xu T, Bianco P, Fisher LW, Longenecker G, Smith E, Goldstein S, Bonadio J, Boskey A, Heegaard AM, Sommer B, Satomura K, Dominguez P, Zhao C, Kulkarni AB, Robey PG, Young MF 1998 Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet 20:7882.
  • 73
    Schultz-Cherry S, Chen H, Mosher DF, Misenheimer TM, Krutzsch HC, Roberts DD, Murphy-Ullrich JE 1995 Regulation of transforming growth factor-β activation by discrete sequences of thrombospondin 1. J Biol Chem 270:73047310.
  • 74
    Taraboletti G, Belotti D, Giavazzi R 1992 Thrombospondin modulates basic fibroblast growth factor activities on endothelial cells. EXS 61:210213.